Company Update Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended June 2020 BSE India No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RONAK NARENDRA LALWANIDesignation :- Company Secretary and Compliance Officer